Skip navigation.
Home

archives

Meet The CEO Interviews BioBalance Corporation's CEO Mr. Dennis O' ...

... colitis, C. difficile infections and antibiotic-associated diarrhea.

New York Health Care, Inc. (the "Company") and BioBalance completed a business combination on January 2, 2003, accounted for ...

FDA Grants Priority Review of Remicade for Treatment of Children ...

... News - FDA Grants Priority Review of Remicade for Treatment of Children With Active Crohn's Disease

All contents Copyright (c) 1995-2006 Doctor's Guide Publishing Limited. All rights reserved ...

A Jekyll and Hyde of cytokines: IL-25 both promotes and limits ...

... A Jekyll and Hyde of cytokines: IL-25 both promotes and limits inflammatory diseases Public release date: 10-Apr-2006

PHILADELPHIA – The same signal responsible for promoting the type of immune ...

'People Helped Me'

... Next>> Subscribe to The Register-Guard >>

Your browser does not support inline frames or is currently configured not to display inline frames. Content may be viewed at http://simg.zedo.com/inte ...

Meet The CEO(TM) Interviews BioBalance Corporation's CEO Mr. ...

... Meet The CEO(TM) Interviews BioBalance Corporation's CEO Mr. Dennis O'Donnell ...